HK1201553A1 - Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains tale dna dna - Google Patents

Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains tale dna dna

Info

Publication number
HK1201553A1
HK1201553A1 HK15101925.1A HK15101925A HK1201553A1 HK 1201553 A1 HK1201553 A1 HK 1201553A1 HK 15101925 A HK15101925 A HK 15101925A HK 1201553 A1 HK1201553 A1 HK 1201553A1
Authority
HK
Hong Kong
Prior art keywords
dna
tale
sensitivity
overcome
binding domains
Prior art date
Application number
HK15101925.1A
Other languages
English (en)
Chinese (zh)
Inventor
Philippe Duchateau
Julien Valton
Original Assignee
Cellectis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectis filed Critical Cellectis
Publication of HK1201553A1 publication Critical patent/HK1201553A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
HK15101925.1A 2012-03-23 2015-02-26 Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains tale dna dna HK1201553A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615011P 2012-03-23 2012-03-23
US201261674083P 2012-07-20 2012-07-20
PCT/IB2013/000721 WO2013140250A1 (fr) 2012-03-23 2013-03-15 Procédé pour surmonter une sensibilité vis-à-vis de modifications chimiques de l'adn de domaines de liaison à l'adn tale synthétique

Publications (1)

Publication Number Publication Date
HK1201553A1 true HK1201553A1 (en) 2015-09-04

Family

ID=48471035

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101925.1A HK1201553A1 (en) 2012-03-23 2015-02-26 Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains tale dna dna

Country Status (10)

Country Link
US (2) US10301614B2 (fr)
EP (1) EP2828384B1 (fr)
JP (1) JP6212535B2 (fr)
CA (1) CA2868055C (fr)
DK (1) DK2828384T3 (fr)
ES (1) ES2683072T3 (fr)
HK (1) HK1201553A1 (fr)
IL (1) IL234797B (fr)
SG (2) SG10201607943RA (fr)
WO (1) WO2013140250A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2683072T3 (es) * 2012-03-23 2018-09-24 Cellectis Método para superar la sensibilidad a modificaciones químicas en el ADN de dominios de unión a ADN de TALE manipulados
CN111500569A (zh) 2014-03-05 2020-08-07 国立大学法人神户大学 特异性转变靶向dna序列的核酸碱基的基因组序列的修饰方法、及其使用的分子复合体
CN108271384B (zh) * 2015-09-09 2022-04-15 国立大学法人神户大学 用于特异性转变靶向dna序列的核酸碱基的革兰氏阳性菌的基因组序列的转变方法、及其使用的分子复合体
US11220693B2 (en) 2015-11-27 2022-01-11 National University Corporation Kobe University Method for converting monocot plant genome sequence in which nucleic acid base in targeted DNA sequence is specifically converted, and molecular complex used therein
EP3214183B1 (fr) * 2016-03-01 2018-11-21 Universität Konstanz Décodage à base d'effecteur de type activateur de la transcription (tale) de cytosine nucléobases par réponse de modification sélective
EP3663310A4 (fr) 2017-08-04 2021-08-11 Peking University Rvd de tale reconnaissant spécifiquement une base d'adn modifiée par méthylation et application correspondante
US11624077B2 (en) 2017-08-08 2023-04-11 Peking University Gene knockout method
EP4149252A2 (fr) * 2020-05-12 2023-03-22 Factor Bioscience Inc. Protéines modifiées d'édition de gènes
WO2022178124A1 (fr) * 2021-02-17 2022-08-25 The Curators Of The University Of Missouri Éditeurs de base cytosine chloroplaste et éditeurs de base cytosine mitochondriale dans des plantes
WO2023060089A2 (fr) * 2021-10-04 2023-04-13 Poseida Therapeutics, Inc. Transposases et leurs utilisations
EP4276174A1 (fr) 2022-05-09 2023-11-15 Cellectis S.A. Thérapie génique pour le traitement du syndrome de pi3kinase delta activé de type 1 (apds1)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
EP3202899B1 (fr) 2003-01-28 2020-10-21 Cellectis Méganucléase sur mesure et son utilisation
US20110239315A1 (en) * 2009-01-12 2011-09-29 Ulla Bonas Modular dna-binding domains and methods of use
EP2206723A1 (fr) * 2009-01-12 2010-07-14 Bonas, Ulla Domaines modulaires de liaison à l'ADN
EP2510096B2 (fr) 2009-12-10 2018-02-07 Regents of the University of Minnesota Modification de l'adn induite par l'effecteur tal
US20140201858A1 (en) 2011-05-17 2014-07-17 Transposagen Biopharmaceuticals, Inc Methods for site-specific genetic modification in stem cells using xanthomonas tal nucleases (xtn) for the creation of model organisms
ES2683072T3 (es) * 2012-03-23 2018-09-24 Cellectis Método para superar la sensibilidad a modificaciones químicas en el ADN de dominios de unión a ADN de TALE manipulados

Also Published As

Publication number Publication date
WO2013140250A1 (fr) 2013-09-26
US20150037809A1 (en) 2015-02-05
US20190338273A1 (en) 2019-11-07
SG10201607943RA (en) 2016-11-29
SG11201405956SA (en) 2014-11-27
DK2828384T3 (en) 2018-07-16
WO2013140250A8 (fr) 2014-11-06
CA2868055A1 (fr) 2013-09-26
US10301614B2 (en) 2019-05-28
IL234797B (en) 2019-02-28
EP2828384A1 (fr) 2015-01-28
JP6212535B2 (ja) 2017-10-11
JP2015510772A (ja) 2015-04-13
US11220683B2 (en) 2022-01-11
ES2683072T3 (es) 2018-09-24
CA2868055C (fr) 2020-06-30
EP2828384B1 (fr) 2018-05-09

Similar Documents

Publication Publication Date Title
HK1201553A1 (en) Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains tale dna dna
HK1213481A1 (zh) 抗體構建體及其使用方法
HK1226105B (zh) 核酸測序的改進方法
IL235128A0 (en) Preparation of a sample of nucleic acids
EP2852687A4 (fr) Procédés de préparation d'un échantillon
HK1201951A1 (en) Data analysis of dna sequences dna
EP2859123A4 (fr) Procédé de détermination de séquence à l'aide d'étiquettes de séquence
EP2912174A4 (fr) Procédé et matériaux pour isoler des matériaux d'acide nucléique
SG11201406408RA (en) Purification of biological molecules
EP2895859A4 (fr) Biocapteur à base de protéase
EP2836221A4 (fr) Procédé d'utilisation de cyclodextrine
HRP20190030T1 (hr) Postupak pročišćavanja protutijela
EP2693876A4 (fr) Réactifs de méthylformyle substitué et procédé d'utilisation de ceux-ci pour modifier des propriétés physicochimiques et/ou pharmacocinétiques de composés
EP2915815A4 (fr) Acide nucléique modifié inédit
HK1212995A1 (zh) 種純化蛋白質的方法
HUE038055T2 (hu) Eljárás szulforafán szintetizálására
HK1208497A1 (en) Method of establishing modified host cell
HK1199903A1 (en) Improved method for manufacture of macrobeads
SG11201402542SA (en) Catalysts for improved cumene production and method of making and using same
EP2770054A4 (fr) Activation d'un acide nucléique fonctionnel par une modification spécifique
GB201215942D0 (en) Method of treatent
GB201210756D0 (en) Analysis of small RNA
GB2522802B (en) Scalable chemical reactor and method of operation thereof
GB201220340D0 (en) Analysis of biopolymer samples
GB201212279D0 (en) Method of construction